Approval · Notice of Compliance 26684 · 2021
ENTOCORT: Notice of Compliance 26684
Issued September 20, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26684
- Date
- September 20, 2021
- Company
- Tillotts Pharma GmbhRheinfelden, Baden-Wuerttemberg, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product¿s labelling material as per the Plain Language Labelling requirements and to update the current Product Monograph (PM) to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTOCORT | Not yet assigned | — |
Medicinal ingredients
- BUDESONIDE 3 MG per CAP